DUBLIN--(BUSINESS WIRE)--The "Direct-to-Consumer Genetic Testing Market Research Report by Type, Channel, Result, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Direct-to-Consumer Genetic Testing Market size was estimated at USD 1,477.98 million in 2021, USD 1,728.32 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 17.11% to reach USD 3,813.66 million by 2027.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Direct-to-Consumer Genetic Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Direct-to-Consumer Genetic Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Direct-to-Consumer Genetic Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Direct-to-Consumer Genetic Testing Market?
4. What is the competitive strategic window for opportunities in the Global Direct-to-Consumer Genetic Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Direct-to-Consumer Genetic Testing Market?
6. What is the market share of the leading vendors in the Global Direct-to-Consumer Genetic Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Direct-to-Consumer Genetic Testing Market?
Market Dynamics
Drivers
- Paradigm shift among consumers seeking greater control over their own healthcare
- Rising awareness about genome testing and risk of genetic diseases
- High aging population coupled with growing prevalence of chronic disorders
- Increased inquisitiveness about the assessment of lineage and ancestry
Restraints
- Related scientific, technical, and clinical issues
- First amendment issues of honesty, fidelity to facts, and truth-in-advertising
Opportunities
- Next-generation sequencing and bio-chip for present and future genetic diagnosis
- Development of online applications to serve customer needs
Challenges
- Complexity of test result interpretation
- Lack of adequate physician knowledge about genetics and potential for genetic discrimination
Companies Mentioned
- 23andMe, Inc.
- 24Genetics
- AlphaBiolabs Ltd
- Ancestry.com LLC
- Atlas Biomed
- Chengdu 23Mofang Biotechnology Co., Ltd.
- Color
- Dante Labs, Inc.
- EasyDNA
- Family Tree DNA
- Full Genomes Corporation, Inc.
- Gene By Gene Ltd.
- Genebase Systems
- Genesis HealthCare
- Helix
- Identigene, L.L.C.
- Karmagenes
- Laboratory Corporation of America, Inc.
- Living DNA
- Mapmygenome
- MyHeritage Ltd.
- Myriad Genetics, Inc.
- Pathway Genomics
- Positive Biosciences, Ltd.
- Quest Diagnostics Incorporated
- Shuwen Biotech Co. Ltd.
- Vitagene, Inc.
- Xcode Life Sciences Pvt Ltd
For more information about this report visit https://www.researchandmarkets.com/r/hbuexe
